These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 13340975)
21. [Usefulness of blood sugar decreasing sulfonamides for insulin shock treatment in psychiatry]. BAYREUTHER H; SPECHT N Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr; 1956; 195(2):132-9. PubMed ID: 13382306 [No Abstract] [Full Text] [Related]
22. Measurements of effects of hyaluronidase in insulin coma treatment. SCHMIDT KE; TONG J J Ment Sci; 1958 Oct; 104(437):1136-48. PubMed ID: 13621159 [No Abstract] [Full Text] [Related]
23. Electric stimulation and insulin coma. HIRSCHFELD G; GIFFEN MB; KLEINMANN MV; HARRIS B Psychiatr Q; 1956 Apr; 30(2):260-6. PubMed ID: 13350432 [No Abstract] [Full Text] [Related]
24. Insulin shock therapy in schizophrenia. DUNN FE J Am Osteopath Assoc; 1947 Dec; 47(4):219-35. PubMed ID: 18910961 [No Abstract] [Full Text] [Related]
25. Use of hyaluronidase in insulin coma. PARGITER RA Dis Nerv Syst; 1957 May; 18(5):194-5. PubMed ID: 13427658 [No Abstract] [Full Text] [Related]
26. Serial electroencephalographic and clinical studies in a case of prolonged insulin coma. SHAGASS C; ROWSELL PW AMA Arch Neurol Psychiatry; 1954 Dec; 72(6):705-11. PubMed ID: 13206489 [No Abstract] [Full Text] [Related]
27. [The psychodynamics in the wake of insulin coma]. LIBERMAN D Neurobiologia; 1948 Jun; 11(2):131-4. PubMed ID: 18894662 [No Abstract] [Full Text] [Related]
28. Combined insulin coma and electric convulsive therapy in schizophrenia. HORWITZ WA; KALINOWSKY LB Am J Psychiatry; 1948 May; 104(11):682-5. PubMed ID: 18864976 [No Abstract] [Full Text] [Related]
29. [Cocarboxylase in insulin shock therapy]. POROT M Ann Med Psychol (Paris); 1955 Jun; 113 2(1):13-5. PubMed ID: 13238929 [No Abstract] [Full Text] [Related]
30. [The problem of BAL action in therapeutic insulin coma]. VOELKEL A Nervenarzt; 1956 Aug; 27(8):369. PubMed ID: 13358822 [No Abstract] [Full Text] [Related]
31. A possible biochemical mechanism underlying the lasting effects of insulin coma and shock therapy. GEIGER A J Neuropsychiatr; 1960; 1():119-23. PubMed ID: 13827110 [No Abstract] [Full Text] [Related]
32. [The influence of metabolism-active substances on therapeutic insulin coma]. FUENFGELD EW Nervenarzt; 1960 Jan; 31():33-6. PubMed ID: 13825545 [No Abstract] [Full Text] [Related]
33. Use of whole protein supplement as an adjunct in insulin coma therapy. DEMOTT JD Am J Psychiatry; 1955 Apr; 111(10):774-5. PubMed ID: 14361764 [No Abstract] [Full Text] [Related]
34. Reversal of evolution in insulin coma. POWER TD J Nerv Ment Dis; 1955 Jun; 121(6):535-44. PubMed ID: 13263940 [No Abstract] [Full Text] [Related]
36. Psychophysiologic resistance in insulin coma therapy. PATTERSON ES J Nerv Ment Dis; 1957; 125(4):547-57. PubMed ID: 13492038 [No Abstract] [Full Text] [Related]
37. [Chlorpromazine and reserpine after insulin shock therapy in schizophrenia]. CARRIE J; FOURNY L; GAYRAL L; HERVE Y Encephale; 1956; 45(4):663-7. PubMed ID: 13384280 [No Abstract] [Full Text] [Related]
38. A comment on insulin coma therapy in schizophrenia. PARFITT DN Am J Psychiatry; 1956 Sep; 113(3):246-7. PubMed ID: 13354788 [No Abstract] [Full Text] [Related]
39. Diabetes mellitus and the Hurler syndrome. A case diabetic coma with deliberate production of Insulin shock to produce recovery. BOHAN EM Med Times; 1963 May; 91():502-9. PubMed ID: 13968453 [No Abstract] [Full Text] [Related]
40. The use of glucagon in insulin coma therapy. BLACKMAN B Psychiatr Q; 1961 Jul; 35():482-7. PubMed ID: 13869689 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]